190 related articles for article (PubMed ID: 27611097)
1. Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer.
Carlier C; Laforce B; Van Malderen SJM; Gremonprez F; Tucoulou R; Villanova J; De Wever O; Vincze L; Vanhaecke F; Ceelen W
J Pharm Biomed Anal; 2016 Nov; 131():256-262. PubMed ID: 27611097
[TBL] [Abstract][Full Text] [Related]
2. Tumor platinum concentration following intraperitoneal administration of cisplatin versus carboplatin in an ovarian cancer model.
Jandial DD; Messer K; Farshchi-Heydari S; Pu M; Howell SB
Gynecol Oncol; 2009 Dec; 115(3):362-6. PubMed ID: 19775736
[TBL] [Abstract][Full Text] [Related]
3. Addressing K/L-edge overlap in elemental analysis from micro-X-ray fluorescence: bioimaging of tungsten and zinc in bone tissue using synchrotron radiation and laser ablation inductively coupled plasma mass spectrometry.
VanderSchee CR; Kuter D; Chou H; Jackson BP; Mann KK; Bohle DS
Anal Bioanal Chem; 2020 Jan; 412(2):259-265. PubMed ID: 31776641
[TBL] [Abstract][Full Text] [Related]
4. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
Los G; Mutsaers PH; Lenglet WJ; Baldew GS; McVie JG
Cancer Chemother Pharmacol; 1990; 25(6):389-94. PubMed ID: 2311166
[TBL] [Abstract][Full Text] [Related]
5. Complementarity of MALDI and LA ICP mass spectrometry for platinum anticancer imaging in human tumor.
Bianga J; Bouslimani A; Bec N; Quenet F; Mounicou S; Szpunar J; Bouyssiere B; Lobinski R; Larroque C
Metallomics; 2014 Aug; 6(8):1382-6. PubMed ID: 24984817
[TBL] [Abstract][Full Text] [Related]
6. Extravasation of Pt-based chemotherapeutics - bioimaging of their distribution in resectates using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS).
Egger AE; Kornauth C; Haslik W; Hann S; Theiner S; Bayer G; Hartinger CG; Keppler BK; Pluschnig U; Mader RM
Metallomics; 2015 Mar; 7(3):508-15. PubMed ID: 25659827
[TBL] [Abstract][Full Text] [Related]
7. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor effects of redox-responsive nanoparticles containing platinum（Ⅳ）in ovarian cancer].
Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
[No Abstract] [Full Text] [Related]
9. An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels.
Zahedi P; Stewart J; De Souza R; Piquette-Miller M; Allen C
J Control Release; 2012 Mar; 158(3):379-85. PubMed ID: 22154933
[TBL] [Abstract][Full Text] [Related]
10. Quantitative mapping of platinum and essential trace metal in cisplatin resistant and sensitive human ovarian adenocarcinoma cells.
Ortega R; Moretto P; Fajac A; Benard J; Llabador Y; Simonoff M
Cell Mol Biol (Noisy-le-grand); 1996 Feb; 42(1):77-88. PubMed ID: 8833669
[TBL] [Abstract][Full Text] [Related]
11. Quantitative bioimaging of platinum group elements in tumor spheroids.
Niehoff AC; Grünebaum J; Moosmann A; Mulac D; Söbbing J; Niehaus R; Buchholz R; Kröger S; Wiehe A; Wagner S; Sperling M; von Briesen H; Langer K; Karst U
Anal Chim Acta; 2016 Sep; 938():106-13. PubMed ID: 27619092
[TBL] [Abstract][Full Text] [Related]
12. Comparison of laser ablation-inductively coupled plasma-mass spectrometry and micro-X-ray fluorescence spectrometry for elemental imaging in Daphnia magna.
Gholap DS; Izmer A; De Samber B; van Elteren JT; Selih VS; Evens R; De Schamphelaere K; Janssen C; Balcaen L; Lindemann I; Vincze L; Vanhaecke F
Anal Chim Acta; 2010 Apr; 664(1):19-26. PubMed ID: 20226927
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal Administration of Neural Stem Cell-Nanoparticle Conjugates Targets Chemotherapy to Ovarian Tumors.
Cao P; Mooney R; Tirughana R; Abidi W; Aramburo S; Flores L; Gilchrist M; Nwokafor U; Haber T; Tiet P; Annala AJ; Han E; Dellinger T; Aboody KS; Berlin JM
Bioconjug Chem; 2017 Jun; 28(6):1767-1776. PubMed ID: 28453256
[TBL] [Abstract][Full Text] [Related]
14. Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy.
Los G; Verdegaal EM; Mutsaers PH; McVie JG
Cancer Chemother Pharmacol; 1991; 28(3):159-65. PubMed ID: 1855272
[TBL] [Abstract][Full Text] [Related]
15. High spatial resolution imaging of cisplatin and Texas Red cisplatin in tumour spheroids using laser ablation isotope dilution inductively coupled plasma mass spectrometry and confocal fluorescence microscopy.
Marković S; Uršič K; Cemazar M; Sersa G; Starešinič B; Milačič R; Ščančar J
Anal Chim Acta; 2021 Jun; 1162():338424. PubMed ID: 33926700
[TBL] [Abstract][Full Text] [Related]
16. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
[TBL] [Abstract][Full Text] [Related]
17. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
[TBL] [Abstract][Full Text] [Related]
18. Quantitative bioimaging by LA-ICP-MS: a methodological study on the distribution of Pt and Ru in viscera originating from cisplatin- and KP1339-treated mice.
Egger AE; Theiner S; Kornauth C; Heffeter P; Berger W; Keppler BK; Hartinger CG
Metallomics; 2014 Sep; 6(9):1616-25. PubMed ID: 24823867
[TBL] [Abstract][Full Text] [Related]
19. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies.
Moreno-Gordaliza E; Giesen C; Lázaro A; Esteban-Fernández D; Humanes B; Cañas B; Panne U; Tejedor A; Jakubowski N; Gómez-Gómez MM
Anal Chem; 2011 Oct; 83(20):7933-40. PubMed ID: 21913725
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Ovarian Cancer Tumors Treated with Intraperitoneal Cisplatin Therapy by Nanoscopic X-ray Fluorescence Imaging.
Laforce B; Carlier C; Vekemans B; Villanova J; Tucoulou R; Ceelen W; Vincze L
Sci Rep; 2016 Jul; 6():29999. PubMed ID: 27444797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
